Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07AXA
|
||||
| Former ID |
DIB007833
|
||||
| Drug Name |
Fatty acid amide hydrolase inhibitors
|
||||
| Synonyms |
Fatty acid amide hydrolase inhibitors (pain/inflammation); FAAH inhibitors (pain/inflammation), Amgen; Fatty acid amide hydrolase inhibitors (pain/inflammation), Amgen
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [552100] | ||
| Company |
Amgen Inc
|
||||
| Canonical SMILES |
n1(c(=O)n(c2c1cccc2)CC)C1CN(c2nccc(n2)c2cc3c(o2)cccc3)C<br />CC1
|
||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [543418] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.